3,843 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Alexion Acquisitions

Alexion has acquired 10 companies and its latest acquisition was Pfizer Inc's Preclinical Gene Therapy Programmes and Enabling Technologies on Jul 2023

Unlock 7 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Pfizer Inc's Preclinical Gene Therapy Programmes and Enabling Technologies

Jul 2023

Source »
$1B
-
LogicBio Therapeutics, Inc.

Oct 2022

Source »
$68M
LogicBio is a Massachusetts-based biotechnology company that researches and develops genetic medicines for the treatment of rare pediatric diseases.
Caelum Biosciences

Sep 2021

Source »
$500M
Caelum Biosciences is a New York-based biotechnology company that develops and commercializes drugs for the treatment of AL amyloidosis and hematologic disorders.
Portola Pharmaceuticals Inc

May 2020

Source »
$1.4B
Portola is a biotechnology company that develops and commercializes novel therapeutics for the treatment of thrombotic and hematologic disorders.
Achillion Pharmaceuticals Inc

Oct 2019

Source »
$930M
Achillion is a biopharmaceutical company that develops drugs for autoimmune diseases.

Frequently Asked Questions about Alexion

  1. What companies did Alexion acquire?

    Companies acquired by Alexion include , LogicBio and Caelum Biosciences

  2. How many acquisitions does Alexion have?

    Alexion has acquired 10 companies including , LogicBio and Caelum Biosciences.

  1. How many acquisitions did Alexion make in 2023?

    In 2023 Alexion acquired 1 companies including undefined.